Stonepine Capital Management, LLC - Mar 31, 2025 SCHEDULE 13G/A Report for Aprea Therapeutics, Inc. Common Stock (APRE)

Filing Manager
Stonepine Capital Management, LLC
Reporting Manager
Stonepine Capital Management, LLC
Security
Aprea Therapeutics, Inc. Common Stock
Symbol
APRE
Shares outstanding
5.57M shares
Disclosed Ownership
239K shares
Ownership
4.3%
Form type
SCHEDULE 13G/A
Date filed
5/14/2025, 04:04 PM
Date of event
Mar 31, 2025
Previous filing
Feb 13, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Stonepine Capital Management, LLC 4.3% 239K 0 239K /s/ Jon M. Plexico Managing Member
Stonepine Capital, L.P. 4.3% 239K 0 239K /s/ Jon M. Plexico Managing Member of the General Partner, Stonepine GP, LLC
Stonepine GP, LLC 4.3% 239K 0 239K /s/ Jon M. Plexico Managing Member
Jon M. Plexico 4.3% 239K 0 239K /s/ Jon M. Plexico Reporting person